---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-014200"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:40:20.018826+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro issues 300,000 shares on conversion of Series B Preferred Stock

## Summary
- Issued 300,000 common shares upon conversion of 696 Series B Preferred shares between Sep 17-25, 2025.
- Common shares outstanding as of Sep 25, 2025: 3,439,861.
- Shares issued in reliance on Section 4(a)(2) exemption; no registration.

## SEC filing metadata
- accession: 0001214659-25-014200
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/0001214659-25-014200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/w9252538k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-014200
- JSON: https://secwatch.observer/filing/0001214659-25-014200.json
- Plain text: https://secwatch.observer/filing/0001214659-25-014200.txt

## Key facts
- Equity Issuances
  Alzamend Neuro, Inc. issued 300,000 shares of common stock of common stock to Series B Convertible Preferred Stock holders for conversion of 696 shares of Series B Convertible Preferred Stock.
  - Security: common stock
  - Shares: 300,000 shares of common stock
  - Purchaser: Series B Convertible Preferred Stock holders
  - Consideration: conversion of 696 shares of Series B Convertible Preferred Stock
  source text: Between September 17, 2025 and September 25, 2025, Alzamend Neuro, Inc. (the “ Company ”) issued an aggregate of 300,000 shares of common stock, par value $0.0001 per share (“ Common Stock ”) upon conversion of an aggregate of 696 shares of Series B Convertible Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/0001214659-25-014200-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.